Document is current
Any future updates will be listed below
-
Authors
Wculek, Stefanie K.
Amores-Iniesta, Joaquín
Conde-Garrosa, Ruth
Khouili, Sofía C.
Melero, Ignacio
Sancho, David https://orcid.org/0000-0003-2890-3984
-
Funding
Funding for this research was provided by:
Ministerio de Ciencia, Innovación e Universidades (SAF2016-79040-R, SAF2014-52361-R, SAF2017-83267-C2-1-R)
Comunidad de Madrid (B2017/BMD-3733 Immunothercan)
Instituto de Salud Carlos III (RD16/0015/0018-REEM)
Fondation Acteria
Fundació la Marató de TV3 (201723)
FP7 Ideas: European Research Council (ERC-2016-Consolidator Grant 725091)
European Commission H2020 (635122-PROCROP H2020, 635122-PROCROP H2020)
Fundación Científica Asociación Española Contra el Cáncer
European Molecular Biology Organization (ALTF 438-2016)
Ministerio de Educación, Cultura y Deporte (FPU16/03142)
- License Information
-
More Information
Article History
Received: 22 November 2018
Accepted: 12 March 2019
First Online: 8 April 2019
Ethics approval and consent to participate
: The local ethics committee approved all animal studies. All animal procedures conformed to EU Directive 2010/63EU and Recommendation 2007/526/EC regarding the protection of animals used for experimental and other scientific purposes, enforced in Spanish law under Real Decreto 1201/2005.
: Not applicable.
: IM reports receiving commercial research grants from BMS and ROCHE and serves as a consultant/advisory board member for BMS, Merck-Serono, Roche-Genentech, Genmab, Incyte, Bioncotech, Tusk, Molecular partners F-STAR, Alligator and AstraZeneca. The authors have no additional financial interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
